A protocol governing and describing FranceCoag’s activities has been validated by the joint FranceCoag – MHEMO Scientific Council. It aims to :

• Describe the objectives and missions of the FranceCoag system
• Describe the HCMs eligible for the FranceCoag system
• Describes the inclusion criteria and the criteria for defining the severity of HCM
• Defining the dataset for the FranceCoag system
• Frame data collection methodologies
• Describe data processing methods
• Propose validated procedures for the entire life cycle of FranceCoag data (management of duplicates, management of oppositions, etc.)

The protocol below is therefore subject to change.